Wexford Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-830
Closed -$103K 338
2020
Q3
$103K Buy
+830
New +$103K 0.03% 133
2020
Q2
Sell
-2,984
Closed -$268K 202
2020
Q1
$268K Buy
+2,984
New +$386K 0.1% 78
2019
Q4
Sell
-36,914
Closed -$4.45M 135
2019
Q3
$4.45M Sell
36,914
-120,623
-77% -$15.6M 0.62% 37
2019
Q2
$21.3M Buy
+157,537
New +$19.9M 2.48% 9
2016
Q2
Sell
-6,500
Closed -$507K 124
2016
Q1
$507K Buy
+6,500
New +$454K 0.1% 89
2014
Q4
Sell
-54,700
Closed -$3.86M 76
2014
Q3
$3.86M Buy
+54,700
New +$3.62M 0.35% 45
2013
Q3
Sell
-226,790
Closed -$8.18M 227
2013
Q2
$8.18M Buy
+226,790
New +$8.77M 0.72% 23

Other funds holding HCA

Wexford Capital's HCA Position: Q4 2020 in Review

Wexford Capital sold out of HCA Healthcare (HCA) in Q4 2020, closing a stake of 830 shares — an estimated $103K sold.

Wexford Capital first reported a position in HCA in Q2 2013 and held it in 7 quarters. The position peaked at $21.3M in Q2 2019. 778 funds tracked by Wall St. Rank hold HCA as of Q4 2020.

  • Wexford Capital reported no remaining HCA Healthcare position as of Q4 2020 after selling out during the quarter.
  • Wexford Capital sold 830 HCA Healthcare shares in Q4 2020, an estimated $103K.
  • Wexford Capital first reported a position in HCA Healthcare in Q2 2013 and held it in 7 quarters.
  • Wexford Capital's HCA Healthcare position peaked at $21.3M in Q2 2019.
  • 778 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2020.

Based on Wexford Capital's 13F filing for Q4 2020, filed 16 Feb 2021.